Show simple item record

dc.contributor.authorOwens, Lisa A.
dc.contributor.authorEgan, Aoife M.
dc.contributor.authorCarmody, Louise
dc.contributor.authorDunne, Fidelma
dc.date.accessioned2018-09-20T16:20:55Z
dc.date.available2018-09-20T16:20:55Z
dc.date.issued2016-04-01
dc.identifier.citationOwens, Lisa A. Egan, Aoife M.; Carmody, Louise; Dunne, Fidelma (2016). Ten years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy—the atlantic dip experience. The Journal of Clinical Endocrinology & Metabolism 101 (4), 1598-1605
dc.identifier.issn0021-972X,1945-7197
dc.identifier.urihttp://hdl.handle.net/10379/13380
dc.description.abstractContext: Pregnancy for women with type 1 or type 2 diabetes is a time of increased risk for both mother and baby. The Atlantic Diabetes in Pregnancy program provides coordinated, evidence-based care for women with diabetes in Ireland. Founded in 2005, the program now shares outcomes over its first decade in caring for pregnant women with diabetes. Objective: The objective was to assess improvements in clinical outcomes after the introduction of interventions. Design, Setting, Participants: We retrospectively examined 445 pregnancies in women with type 1 and type 2 diabetes and compared them over two timepoints, 2005-2009 and 2010-2014. Interventions: Interventions introduced over that time include: provision of combined antenatal/diabetes clinics, prepregnancy care, electronic data management, local clinical care guidelines, professional and patient education materials, an app, and a web site. Main Outcomes: Pregnancy outcomes were measured. Results: The introduction of the Atlantic Diabetes in Pregnancy program has been associated with a reduction in adverse neonatal outcomes. There has been a reduction in congenital malformations (5 to 1.8%; P = .04), stillbirths (2.3 vs 0.4%; P = .09), despite an upward trend in maternal age (mean age, 31.7 vs 33 years), obesity (29 vs 43%; body mass index >30 kg/m(2)), and excessive gestational weight gain (24 vs 38%; P = .002). These improvements in outcomes occur alongside an increase in attendance at prepregnancy care (23 to 49%; P = .001), use of folic acid (45 vs 71%; P = .001), and sustained improvement in glycemic control. Conclusions: Changing the process of clinical care delivery and utilizing evidence-based interventions in a pragmatic clinical setting improves pregnancy outcomes for women with pregestational diabetes. We now need to target optimization of maternal body mass index before pregnancy and put a greater focus on gestational weight gain through education and monitoring.
dc.publisherThe Endocrine Society
dc.relation.ispartofThe Journal of Clinical Endocrinology & Metabolism
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectgestational weight-gain
dc.subjectcongenital-malformations
dc.subjectprepregnancy care
dc.subjectpreconception care
dc.subjectcesarean-section
dc.subjectfetal outcomes
dc.subjectrisk
dc.subjectinsulin
dc.subjectmetformin
dc.subjectmetaanalysis
dc.titleTen years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy—the atlantic dip experience
dc.typeArticle
dc.identifier.doi10.1210/jc.2015-3817
dc.local.publishedsourcehttps://academic.oup.com/jcem/article-pdf/101/4/1598/10429311/jcem1598.pdf
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland